tetano
Editor, Senior Moderator
Viroblock SA a Swiss start-up today presented new data at ICPIC 2013 in Geneva showing that their face-mask containing proprietary novel cholesterol depletion technology traps and kills over 99.9995% of H1N1 flu viruses (swine flu) 99.999% of H5N1 flu viruses (avian flu) and 99.997% human corona viruses on pass through air. Aimed at helping protect people from these respiratory pathogens the mask is up to one hundred times more effective than a similar mask without Viroblock technology. The company will now start direct sales in Switzerland and is looking for distributors in other countries.
?Aerobiology tests for face-masks simulate real life situations in which the user is exposed to viruses coming in. The mask helps prevent transmission from and to the person wearing the mask.? commented Dr Thierry Pelet CSO at Viroblock. ?The stringent testing demonstrates the efficacy and speed at which the cholesterol depletion technology works?.
Read more: http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=76171#.Ucq8YtgSofg#ixzz2XJc1cbEx
Pharma Jobs and News
?Aerobiology tests for face-masks simulate real life situations in which the user is exposed to viruses coming in. The mask helps prevent transmission from and to the person wearing the mask.? commented Dr Thierry Pelet CSO at Viroblock. ?The stringent testing demonstrates the efficacy and speed at which the cholesterol depletion technology works?.
Read more: http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=76171#.Ucq8YtgSofg#ixzz2XJc1cbEx
Pharma Jobs and News